Satoshi Yuki

15PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors.

|Jul 29, 2025
Urinary Titin as a Non-Invasive Biomarker for Sarcopenia Sex Differences in Unresectable Digestive Malignancies: A Retrospective Cohort Study.

Shiho Kaneko, Kazuaki Harada, Masatsugu Ohara

|Jun 02, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.

Tadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura

|Aug 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer.

Naoko Iida, Mitsuho Imai, Wataru Okamoto

|Jul 18, 2024
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine.

Tadayoshi Hashimoto, Yoshiaki Nakamura, Takao Fujisawa

|Nov 14, 2023
Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).

Takeshi Kajiwara, Tomohiro Nishina, Riu Yamashita

Pageof 3

Frequent Collaborators

8 joint publications

Yoshito Komatsu

7 joint publications

Hideaki Bando

6 joint publications

Takayuki Yoshino

4 joint publications

Hiroki Hara